INS and type 1 diabetes mellitus: Our animal experiment further revealed that the daily low-dose injection of LPS for six weeks could induce comprehensive inflammatory responses in the pancreas on the transcriptome level, aggravate islet lesion, reduce the number of insulin-positive islets and serum C-peptide level in the LPS-treated T1D mice, which may explain the disruption of glucose metabolism.